COVID-19 emerged from China in December 2019 and during 2020 spread to every
continent including Antarctica. The coronavirus, SARS-CoV-2, has been identified as the …

Azithromycin (AZM) is commonly used in Covid‐19 patients based on low‐quality evidence,
increasing the risk of developing adverse events and antimicrobial resistance. The current …

Background There is on-going controversy regarding the potential for increased respiratory
effort to generate patient self-inflicted lung injury (P-SILI) in spontaneously breathing …

Neurological manifestations are increasingly reported in a subset of COVID-19 patients.
Previous infections related to coronaviruses, namely Severe Acute Respiratory Syndrome …

Acute respiratory distress syndrome (ARDS) remains a serious illness with significant
morbidity and mortality, characterized by hypoxemic respiratory failure most commonly due …

Co-infection with ancillary pathogens is a significant modulator of morbidity and mortality in
infectious diseases. There have been limited reports of co-infections accompanying SARS …

Introduction Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been
caused the greatest pandemic of our century. Many of the deaths related to it are due to a …

COVID-19 patients are oftentimes over-or under-treated due to a deficit in predictive
management tools. This study reports derivation of an algorithm that integrates the host …

With more than 53 million cases of severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) infection worldwide (at the time of writing) and the recent new increase in contagion …

Abstract Background Patients with severe Coronavirus disease 19 (COVID-19) typically
require supplemental oxygen as an essential treatment. We developed a machine learning …